Screening for more with less: Validation of the Global Appraisal of Individual Needs Quick v3 (GAIN-Q3) screeners.

Journal of Substance Abuse Treatment
Michael L Dennis, Jordan P Davis

Abstract

Multi-morbidity is the norm among adolescents and adults with substance use and other mental disorders and warrants a multi-pronged screening approach. However, the time constraints on assessment inherent in clinical practice often temper the desire for a full understanding of multi-morbidity problems. The 15- to 25-minute Global Appraisal of Individual Needs Quick version 3 (GAIN-Q3) includes screeners for 9 common clinical problems that are short (4 to 10 items) and provide dimensional measures of problem severity in each area that are also categorized to guide clinical decision making. The screeners are summed into a total score that represents a 10th screener for multi-morbidity. This paper provides background on the development of the GAIN-Q3 screeners, their psychometric behaviors, efficiency, and predictive power relative to the 1-2 h full GAIN-I. Based on literature showing differential item and scale functioning by age, analyses were conducted separately using data from 10,625 adolescent and 10,167 adult treatment clients. Despite the condensed lengths of the screening measures compared with their longer versions, the reliability estimates are within the good to excellent range (0.7 to 0.9) in terms of internal consist...Continue Reading

References

Mar 1, 1979·Journal of Affective Disorders·R S LipmanA K Shapiro
Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Jul 1, 1955·Psychological Bulletin·L J CRONBACH, P E MEEHL
Oct 27, 2004·Journal of Substance Abuse Treatment·Michael DennisRod Funk
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Dec 22, 2005·Drug and Alcohol Dependence·Richard LennoxRod Funk
Mar 7, 2006·General Hospital Psychiatry·Benjamin G Druss, Silke A von Esenwein
Nov 30, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Claudia DiederichsDorothee B Bartels
Feb 3, 2011·The American Journal of Psychiatry·Rachel L GarfieldJulie M Donohue
Dec 6, 2011·Journal of Substance Abuse Treatment·Janet C TitusMichelle K White
Apr 5, 2012·Archives of General Psychiatry·Ronald C KesslerKathleen Ries Merikangas
Dec 20, 2014·Postgraduate Medicine·Najla A Lakkis, Dina M Mahmassani
Mar 10, 2015·European Child & Adolescent Psychiatry·Thomas JozefiakLars Wichstrøm
May 13, 2015·Journal of Clinical Epidemiology·Kurt KroenkeJacob Kean
Jul 15, 2015·Health Affairs·Christina AndrewsHarold A Pollack
Jun 9, 2016·Health Affairs·Timothy B Creedon, Benjamin Lê Cook
Feb 23, 2017·Health Economics·Johanna Catherine Maclean, Brendan Saloner
Mar 28, 2017·Journal of Clinical Epidemiology·Henrica C W de VetCaroline B Terwee
Sep 28, 2017·Journal of General Internal Medicine·Norah Mulvaney-DaySushmita Shoma Ghose
Dec 7, 2017·Psychological Science in the Public Interest : a Journal of the American Psychological Society·Lee Anna ClarkGeoffrey M Reed
Jun 27, 2018·Frontiers in Public Health·Godfred O BoatengSera L Young
Apr 26, 2019·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Kathryn NicholsonMartin Fortin
Jun 17, 2019·Journal of Substance Abuse Treatment·Christina M AndrewsPeter D Friedmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.